These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6832651)

  • 1. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen.
    Jespersen J; Ingeberg S; Bach E
    Gynecol Obstet Invest; 1983; 15(3):153-62. PubMed ID: 6832651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential study of plasma euglobulin fibrinolytic activity during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J
    Gynecol Obstet Invest; 1983; 15(5):266-74. PubMed ID: 6852646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptive agents and antithrombin III].
    Kamenov V; Nalbanski B
    Akush Ginekol (Sofiia); 1990; 29(1):60-3. PubMed ID: 1695492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral contraceptives on platelet noradrenaline and5-hydroxytryptamine receptors and aggregation.
    Peters JR; Elliott JM; Grahame-Smith DG
    Lancet; 1979 Nov; 2(8149):933-6. PubMed ID: 91026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood platelet biochemistry in women receiving steroid contraceptives.
    Briggs M
    Haematologia (Budap); 1973; 7(3):347-67. PubMed ID: 4790074
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in insulin receptors during oral contraception.
    De Pirro R; Forte F; Bertoli A; Greco AV; Lauro R
    J Clin Endocrinol Metab; 1981 Jan; 52(1):29-33. PubMed ID: 7451643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual levels of plasma alpha 2-antiplasmin and alpha 2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Sidelmann J
    Thromb Haemost; 1983 Aug; 50(2):581-5. PubMed ID: 6195752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tsh and serum t3 levels during normal menstrual cycles and during cycles on oral contraceptives.
    Weeke J; Hansen AP
    Acta Endocrinol (Copenh); 1975 Jul; 79(3):431-8. PubMed ID: 1173500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal content of plasma and endometrium of women taking oral contraceptives.
    Porias H; Carranco-López A; Sojo-Aranda I; González-Martínez R; Cervantes C; Parra A; Cortés-Gallegos V
    Obstet Gynecol; 1978 Dec; 52(6):703-7. PubMed ID: 733138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of hormonal contraceptives on menstrual and reproductive function of women].
    Dubnitskaia LV; Sotnikova EI
    Akush Ginekol (Mosk); 1990 Apr; (4):57-60. PubMed ID: 1696071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in coagulation factors and platelet function in response to progestational agents.
    McGrath KM; Castaldi PA
    Haemostasis; 1975; 4(2):65-72. PubMed ID: 1205337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of hormonal contraceptives in the spectrum of free plasma amino acids].
    Klinger G; Gruhn K
    Dtsch Gesundheitsw; 1978; 33(50):2373-7. PubMed ID: 729470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the contraceptive pill on sedative responses to clonidine and apomorphine in normal women.
    Chalmers JS; Fulli-Lemaire I; Cowen PJ
    Psychol Med; 1985 May; 15(2):363-7. PubMed ID: 2991959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The menstrual cycle during Edival treatment. Results of a field study].
    Heithecker R; Laengner H
    ZFA (Stuttgart); 1979 Sep; 55(26):1455-6. PubMed ID: 483984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.